A Study to Evaluate Single Doses of Alpha-0261 in Healthy Adult Volunteers

Alpha-0261 - Shenzhen Alpha Molecular Technology

A Study to Evaluate Single Doses of Alpha-0261 in Healthy Adult Volunteers (clinicaltrials.gov) - Jun 30, 2026 - P1 | N=55 | Completed | Sponsor: AlphaMol Science Ltd. (Shanghai) | Recruiting ➔ Completed
Trial completion

http://clinicaltrials.gov/ct2/show/NCT07279636

Jun 30, 2026